Decalcification Protocol
GUIDELINE
- Decalcification is required for processing bone tissue in routine diagnostic practice. Control of this step is crucial because it may have important consequences for establishing the diagnosis.
- Agents commonly used for decalcification are acids of varying ionic strength or chelating agents. Acids that ionize and solubilize calcium ions include strong inorganic acids, such as hydrochloric or nitric acid, and weaker organic acids such as formic or phosphoric acid. Chelating agents such as ethylenediaminetetraacetic acid (EDTA) link to calcium ions and form an insoluble complex.
METHODS
Routine Decalcification
- Make 14% EDTA solution. Add 140 g free acid EDTA to 700 ml distilled H2O. On stir plate in the fume hood, add ammonium hydroxide 30 ml at a time until solution clears (about 90 ml total). Add H2O to almost 1 L. Check pH and adjust with ammonium hydroxide dropwise up to pH 7.2, then adjust final volume to 1 L.
- Place fixed / rinsed tissue in at least 15 volumes of 14% EDTA, and change daily or 5x / week (M-F) with mixing, this means at least 15 ml for a mouse tibia / femur. Placing tissue in a screw-top tube on its side, on a rocker works well. We tape tubes into a rack and place the whole thing on its side on the rocker.

- Time of decalcification varies with tissue size, species, etc. Mouse adult long bones and vertebrae need 10-14 days, and isolated calvaria needs 2-4 days.
- Rinse in H2O x 4. For paraffin embedding, place in 30%, 50%, and 70% ETOH for at least 30 min each prior to submitting to core lab; For frozen sections, blot tissue dry and freeze in OCT.
Hurry-Up Decalcification
- Reagent preparation. We need prepare 12.6 g aluminum chloride (hydrous), 8.5 ml 10 N hydrochloric acid, 5.4 ml 88% formic acid.
- Make final volume to 100 ml. Dilute 1 part of this stock solution with 4 parts of dH2O for LM histology (or immunohistochemistry) and 1:8 for tissues being processed for EM.
- Decalcification of an entire head of a 100 g rat takes only about 5 days in this solution at 1:4 dilution. It is truly amazing how quickly it works and how reasonable the tissues look afterwards.
- We usually do the decalcification at 4°C as with EDTA (with stirring, large fluid to tissue ratio). You should change this solution daily. Wash the tissues liberally after decalcification as with EDTA.
NOTES
- The fluid volume to tissue ratio is very critical for the decalcification process. It should be as large as practical, for example, no more than 10 or 15 hemi-jaws per liter of solution.
- You should change the solution every other day, pre chill the new batch to keep temperature at 4°C at all times.
- It is important to clean away as much muscle and soft tissues from the hemi-jaw bones, excess tissues act as a barrier to the decalcification process.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- How to Handle Mycoplasma in Cell Culture?
- CHO Cell Line Development
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- How to Isolate PBMCs from Whole Blood?
- Comparison of the MSCs from Different Sources
- T Cell Activation and Expansion
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Tips For Cell Cryopreservation
- Quantification of Cytokines
- Organoid Differentiation from Induced Pluripotent Stem Cells
- What are the Differences Between M1 and M2 Macrophages?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- How to Assess the Migratory and Invasive Capacity of Cells?
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- How to Decide Between 2D and 3D Cell Cultures?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- How to Eliminate Mycoplasma From Cell Cultures?
- What Are Myeloid Cell Markers?
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- What are PBMCs?
- Cryopreservation of Cells Step by Step
- How to Start Your Culture: Thawing Frozen Cells
- Techniques for Cell Separation
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Cell Cryopreservation Techniques and Practices
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Human Primary Cells: Definition, Assay, Applications
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- STR Profiling—The ID Card of Cell Line
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- Cell Culture Medium
- Direct vs. Indirect Cell-Based ELISA
- What Is Cell Proliferation and How to Analyze It?
- IL-12 Family Cytokines and Their Immune Functions
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- Understanding Immunogenicity Assays: A Comprehensive Guide
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Role of Cell-Based Assays in Drug Discovery and Development
- 3D-Cell Model in Cell-Based Assay
- Immunogenicity Testing: ELISA and MSD Assays
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- What Are the Pros and Cons of Adoptive Cell Therapy?
- 3D-Cell Model in Cell-Based Assay
- Immunogenicity Testing: ELISA and MSD Assays
- Cultivated Meat: What to Know?
- Eosinophils vs. Basophils vs. Neutrophils
- Cell Viability, Proliferation and Cytotoxicity Assays
- What Are CAR T Cells?
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Optimization Strategies of Cell-Based Assays
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- Overview of Cell Apoptosis Assays
- Cell-Based High-Throughput Screening Techniques
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Cell Immortalization Step by Step
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
- Adherent and Suspension Cell Culture
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
-
Histology
- Troubleshooting in Fluorescent Staining
- Fluorescent Nuclear Staining Dyes
- Guides for Live Cell Imaging Dyes
- Overview of the FFPE Cell Pellet Product Lines
- Immunohistochemistry Controls
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- Multiple Animal Tissue Arrays
- Tips for Choosing the Right Protease Inhibitor
- Mitochondrial Staining
- Stains Used in Histology
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Cell Lysates: Composition, Properties, and Preparation
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- Overview of Common Tracking Labels for MSCs
- How to Apply NGS Technologies to FFPE Tissues?
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- How to Begin with Multiplex Immunohistochemistry (mIHC)
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- Serum vs. Plasma
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- Modern Histological Techniques
- Multiplexing Immunohistochemistry
- What You Must Know About Neuroscience IHC?
- How Immunohistochemistry Makes the Invisible Brain Visible?
- From Specimen to Slide: Core Methods in Histological Practice
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
-
Exosome
- What's the Potential of PELN in Disease Treatment?
- Classification, Isolation Techniques and Characterization of Exosomes
- Emerging Technologies and Methodologies for Exosome Research
- How to Enhancement Exosome Production?
- How to Label Exosomes?
- How to characterize exosomes?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
- Exosomes as Emerging Biomarker Tools for Diseases
- How to Apply Exosomes in Clinical?
- How to Perform Targeted Modification of Exosomes?
- Exosome Quality Control: How to Do It?
- Exosome Transfection for Altering Biomolecular Delivery
- Summary of Approaches for Loading Cargo into Exosomes
- Collection of Exosome Samples and Precautions
- Techniques for Exosome Quantification
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Common Techniques for Exosome Nucleic Acid Extraction
- How Important are Lipids in Exosome Composition and Biogenesis?
- What are the Functions of Exosomal Proteins?
- Exosome Size Measurement
- The Role of Exosomes in Cancer
- Applications of MSC-EVs in Immune Regulation and Regeneration
- Unraveling Biogenesis and Composition of Exosomes
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- Exosome Antibodies
-
ISH/FISH
- ISH probe labeling method
- Reagents Used in FISH Experiments
- CARD-FISH: Illuminating Microbial Diversity
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- RNAscope ISH Technology
- What are the Differences between FISH, aCGH, and NGS?
- Comparative Genomic Hybridization and Its Applications
- What are Single, Dual, and Multiplex ISH?
- Differences Between DNA and RNA Probes
- What Is the Use of FISH in Solid Tumors?
- Mapping of Transgenes by FISH
- Overview of Oligo-FISH Technology
- What Types of Multicolor FISH Probe Sets Are Available?
- FISH Tips and Troubleshooting
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Telomere Length Measurement Methods
- Guidelines for the Design of FISH Probes
- Overview of Common FISH Techniques
- Multiple Approaches to Karyotyping
- In Situ Hybridization Probes
- Small RNA Detection by ISH Methods
- Different Types of FISH Probes for Oncology Research
- How to Use FISH in Hematologic Neoplasms?
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- Toxicokinetics vs. Pharmacokinetics
- Physical and Chemical Properties of Drugs and Calculations
- Pharmacokinetics of Therapeutic Peptides
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- How to Improve Drug Plasma Stability?
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Key Considerations in Toxicokinetic
- Experimental Methods for Identifying Drug-Drug Interactions
- How to Conduct a Bioavailability Assessment?
- Organ-on-a-Chip Systems for Drug Screening
- Traditional vs. Novel Drug Delivery Methods
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- Methods of Parallel Artificial Membrane Permeability Assays
- Key Factors Influencing Brain Distribution of Drugs
- Unraveling the Role of hERG Channels in Drug Safety
- The Rise of In Vitro Testing in Drug Development
- Overview of In Vitro Permeability Assays
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- What Are Compartment Models in Pharmacokinetics?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- From Cells to Systems: Modern Approaches to Disease Modeling
- How Genotoxicity Testing Guides Safer Drug Development
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- What Are the Best Methods to Test Cardiotoxicity?
- Why Cardiotoxicity Matters in R&D?
-
Disease Models
- Preclinical Models of Acute Liver Failure
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Animal Models of Neurodegenerative Diseases
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Disease Models of Diabetes Mellitus
- Why Use PDX Models for Cancer Research?
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter

